Smart Cupboard-based System for Memory Assessment in Alzheimer's Patients

The main objective of the research is to create a tool that can make a good diagnosis of cognitive abilities in Alzheimer's patients. As a secondary objective, the investigators intend to examine both the percentage of correct answers and the response times and see their relationship with age, gender, sex, months since the onset of the disease and years of training.

Study Overview

• Status: Completed
• Conditions: Alzheimer Disease; Cognitive Decline
• Intervention / Treatment: Other: Smart cupboard

• Study Type: Observational
• Enrollment (Actual): 13

Contacts and Locations

Study Locations

• Spain
  • Teruel, Spain, 44003
    • University of Zaragoza

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Community dwelling Alzheimer's patients who attend the Alzheimer's and dementia center in Teruel on a regular basis.

Description

Inclusion Criteria:

1. Being over 18 years.
2. Provide signed informed consent.
3. Have the ability to understand the study.

Exclusion Criteria:

Having any physical or medical problem that prevents or advises them not to stand upright, in a bipedal position.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Experimental; Alzheimer´s patients	Other: Smart cupboard; Development of a memory task with the help of a smart cupboard

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Accuracy response.	Number of successes / failures on the total of questions	60 minutes
Reaction time	Defined as the time it takes the subject to answer each of the questions.	60 minutes

Collaborators and Investigators

• Sponsor: Universidad de Zaragoza

Study record dates

Study Major Dates

• Study Start (Actual): October 30, 2021
• Primary Completion (Actual): November 20, 2021
• Study Completion (Actual): November 20, 2021

Study Registration Dates

• First Submitted: January 9, 2022
• First Submitted That Met QC Criteria: January 9, 2022
• First Posted (Actual): January 21, 2022

Study Record Updates

• Last Update Posted (Actual): February 7, 2022
• Last Update Submitted That Met QC Criteria: January 21, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurocognitive Disorders; Neurodegenerative Diseases; Dementia; Tauopathies; Cognition Disorders; Alzheimer Disease; Cognitive Dysfunction
• Other Study ID Numbers: PI21/326

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No